Clinical Trial Update: Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating Bryostatin 1 in Alzheimer's disease was terminated, with results posted in 2016 assessing safety, efficacy, pharmacokinetics and ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: Neurotrope Bioscience, Inc. | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-04-21